Hillsdale Investment Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-310
| Closed | -$7.32K | – | 699 |
|
|
2023
Q4 | $7.32K | Sell |
310
-30
| -9% | -$709 | ﹤0.01% | 466 |
|
|
2023
Q3 | $5.07K | Buy |
+340
| New | +$5.07K | ﹤0.01% | 510 |
|
|
2021
Q1 | – | Sell |
-123,300
| Closed | -$708K | – | 703 |
|
|
2020
Q4 | $708K | Sell |
123,300
-40,000
| -24% | -$230K | 0.07% | 263 |
|
|
2020
Q3 | $1.18M | Sell |
163,300
-53,000
| -25% | -$384K | 0.12% | 169 |
|
|
2020
Q2 | $755K | Buy |
+216,300
| New | +$755K | 0.07% | 240 |
|
|
2018
Q2 | – | Sell |
-8,000
| Closed | -$104K | – | 563 |
|
|
2018
Q1 | $104K | Buy |
+8,000
| New | +$104K | 0.01% | 281 |
|